ziftomenib
kura oncology,syndax pharma
['leukemia', 'myeloid']
kura's menin inhibitor worked in one of two acute myeloid leukemia subsets, with differentiation syndrome leading to a setback in one group that will require a combo drug study going forward 
covering the science, people, $ & biotechs behind new drugs @Endpts | klahucik@endpointsnews.com | askin Qs, joggin 26.2 | ?? ?? ?? | XC coach | he/him ??????